SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Biotech Valuation
CRSP 53.80+2.6%Jan 2 9:30 AM EST
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: NeuroInvestment who wrote (23485)4/18/2007 9:48:11 AM
From: scaram(o)uche   of 52153
 
Thanks Harry -- certain from the thread as a whole -- for your thoughts.

I once gave it some thought.... who should be responsible for labeling a medicine "me too!"? I came up with a large, low-compensation panel of FASEB-appointed sorts.

But my view of FDA is different than most.... I see good scientists who want to expedite new, safe medicines. And, again, this was an advisory committee, not FDA. The vote was trickle down from cardio thought honchos.... justifiable trickle down, imo.

Best! Rick
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News